Abstract: A method and apparatus for determining oversensing in a medical device that includes sensing cardiac signals, determining an oversensing characteristic associated with cardiac signals sensed during a predetermined sensing window, identifying oversensing in response to the oversensing characteristic, determining, in response to oversensing being identified, an adjusting characteristic associated with cardiac signals sensed during the predetermined sensing window, and updating a sensing parameter in response to the determined adjusting characteristic.

Abstract: A method and apparatus of updating a sensing parameter in a medical device that includes sensing cardiac signals, determining intervals in response to the sensed cardiac signals, determining interval patterns associated with the determined intervals, and updating the sensing parameter in response to the determined interval patterns.

Abstract: A method and apparatus for adjusting a sensing parameter in a medical device that includes a sensing electrode sensing cardiac signals, a processor to determine an adjusting characteristic associated with the cardiac signals sensed over a predetermined sensing window, and a control unit to update the sensing parameter in response to the determined adjusting characteristic.

Abstract: A method and apparatus for determining oversensing of cardiac signals that includes a housing containing electronic circuitry, an electrode coupled to the electronic circuitry to sense cardiac signals, and a processor, positioned within the housing, to determine an oversensing characteristic associated with the cardiac signals sensed over a predetermined sensing window, and to identify oversensing in response to the determined oversensing characteristic.

Abstract: An implantable medical device and associated method store physiological data in response to detecting a physiological event. The medical device includes multiple first memory locations allocated to each of a number of physiological event types and a second single memory location allocated for storing entries of physiological signal data corresponding to each of the plurality of physiological event types.

Abstract: A method of operating a cardiac pacing device that optimizes the mechanical heart rate using coordinated potentiation therapy while maximizing the opportunity for intrinsic AV conduction to occur. The method may include adjusting the timing of extra stimulus intervals during coupled or paired pacing to promote AV conduction and to effect changes in rate according to certain embodiments of the invention. Other embodiments may include adjusting the atrial pacing rate to achieve a desired target rate consistent with AV conduction. A mode switch to a dual-chamber pacing mode may be provided according to certain embodiments of the invention to ensure a ventricular rate that meets or exceeds a minimum mechanical rate.

Abstract: The invention provides systems to prevent the delivery of anti-tachycardia pacing (ATP) following a defibrillation threshold (DFT) induction at implant. An algorithm that classifies episodes as induced or spontaneous is implemented, thereby enabling the ATP during charging feature to be operable only when spontaneous episodes are detected while temporarily suspending the ATP feature during the delivery of defibrillation shock after induction has been confirmed. Further, a user interface enables users to interact with an implantable medical device (IMD), particularly for setting a defibrillation threshold (DFT) or a 50 Hz burst from a single programmer screen. The user interface includes various functionalities to promote quick user access to parameters that govern diagnosis, therapy and other features of the IMD. A single screen enables the user to complete automatic and/or manual DFT inductions or a 50 Hz burst from a programmer interface while acquiring associated documentation from the same interface.

Abstract: A system and method for treating an arrhythmia of the heart, involves delivery of anti-tachy pacing (ATP) pulses to the heart, possibly followed by the delivery of a high-voltage shock. ATP delivery is controlled such that the time delivery of any high-voltage shock is not affected by the prior delivery of the ATP pulses. System control may be accomplished using one or more programmable parameters, which may include a user-specified shock energy.

Abstract: The present invention provides a system and method for treating an arrhythmia of the heart. The system and method involves delivery of anti-tachy pacing (ATP) pulses to the heart, possibly followed by the delivery of a high-voltage shock. ATP delivery is controlled such that the time of delivery of any high-voltage shock is not affected by the prior delivery of the ATP pulses. System control may be accomplished using one or more programmable parameters, which may include a user-specified shock energy.

Abstract: The invention provides systems to prevent the delivery of anti-tachycardia pacing (ATP) following a defibrillation threshold (DFT) induction at implant. An algorithm that classifies episodes as induced or spontaneous is implemented, thereby enabling the ATP during charging feature to be operable only when spontaneous episodes are detected while temporarily suspending the ATP feature during the delivery of defibrillation shock after induction has been confirmed. Further, a user interface enables users to interact with an implantable medical device (IMD), particularly for setting a defibrillation threshold (DFT) or a 50 Hz burst from a single programmer screen. The user interface includes various functionalities to promote quick user access to parameters that govern diagnosis, therapy and other features of the IMD. A single screen enables the user to complete automatic and/or manual DFT inductions or a 50 Hz burst from a programmer interface while acquiring associated documentation from the same interface.